SNPS News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

SN

Mkt Cap

$73.77B

Volume

1.40M

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Arteris 加速行业向 Multi-Die 芯粒架构转型Arteris announced an expansion of its Multi-Die product portfolio to help semiconductor companies transition from monolithic SoCs to chiplet architectures for AI, HPC, and consumer electronics. The new FlexGen Multi-Die NoC IP extends on-chip network connectivity across chip boundaries, reducing PHY area, power, and I/O requirements by up to 50%. The expanded solution includes FlexGen Multi-Die, Ncore Multi-Die, Magillem integration automation, and Cycuity hardware security verification, with support from major partners including AMD, Socionext, Cadence, Synopsys, and others.GlobeNewswire Inc. · Sep 15, 2026

Arteris, 업계의 Multi-Die 칩렛 기반 아키텍처 전환 가속화Arteris announced an expanded Multi-Die portfolio including the new FlexGen Multi-Die product to help semiconductor companies transition from monolithic SoC designs to chiplet-based architectures. The solution extends Network-on-Chip (NoC) connectivity across die boundaries while maintaining QoS and architectural flexibility, addressing data movement challenges in AI and high-performance computing systems.GlobeNewswire Inc. · Sep 15, 2026

Arteris、マルチダイ／チップレットベースアーキテクチャへの業界移行を加速Arteris announced an expanded multi-die product portfolio including the new FlexGen Multi-Die solution, enabling semiconductor manufacturers to transition from monolithic SoC designs to chiplet-based architectures while maintaining QoS and design flexibility. The solution addresses challenges in AI, HPC, and consumer electronics by seamlessly extending NoC connectivity across chip boundaries, reducing PHY area and power consumption by up to 50%.GlobeNewswire Inc. · Sep 15, 2026

CEVA Stock Slides 19% in a Month: Should You Buy the Dip or Wait?CEVA Inc. shares fell 18.7% over the past month following profit-taking after reaching a 52-week high of $51.60 in June amid AI hype. Despite beating Q2 earnings estimates with 8 cents per share (vs. 7 cents consensus) and 13% revenue growth to $29M, investors were unimpressed. The stock trades at a premium valuation of 5.66X forward sales versus its sub-industry average of 4.04X. Analysts recommend patience, citing a Hold rating due to the disconnect between favorable growth prospects and expensive valuation.Zacks Investment Research · Sep 1, 2026

Is It Worth Investing in Synopsys (SNPS) Based on Wall Street's Bullish Views?Synopsys (SNPS) has a strong average brokerage recommendation of 1.59 (Strong Buy/Buy) from 22 firms, with 16 Strong Buy ratings. However, the article cautions that brokerage recommendations often carry positive bias due to institutional vested interests. The company's Zacks Rank #2 (Buy) rating is supported by a 3.3% increase in consensus earnings estimates over the past month to $15.06, suggesting legitimate near-term upside potential.Zacks Investment Research · Sep 1, 2026

Here's How Much You'd Have If You Invested $1000 in Synopsys a Decade AgoA $1,000 investment in Synopsys (SNPS) made in September 2016 would have grown to $7,414.24 by September 2026, representing a 641.42% gain—significantly outperforming the S&P 500's 254.05% return. The company benefits from recurring revenue, strong demand for chip design and AI-related tools, and the Ansys acquisition expansion, though elevated debt and execution risks remain concerns.Zacks Investment Research · Sep 1, 2026

This AI Energy Stock Is Up Nearly 2,000% in the Last Two Years. Could It Be Nvidia's Next Big Investment?Nvidia has built a $63.4 billion portfolio of AI infrastructure partners including Intel, SpaceX, CoreWeave, and Synopsys. As energy becomes a critical bottleneck for AI data center growth, Bloom Energy—a hydrogen fuel-cell company that recently crossed $1 billion in quarterly revenue and signed a $25 billion partnership with Brookfield Asset Management—emerges as a potential candidate for Nvidia investment.The Motley Fool · Aug 28, 2026

Why Synopsys Stock Popped TodaySynopsys stock surged over 11% after beating analyst expectations for fiscal Q3 earnings and sales. The company reported $3.91 EPS on $2.5B in sales versus forecasts of $3.67 EPS on $2.4B. Strong growth was driven by increased demand for AI chip design software, with sales up 42.5% year-over-year. The company also generated $2.1B in free cash flow year-to-date, more than 3x its reported GAAP profits, and provided optimistic full-year guidance.The Motley Fool · Aug 27, 2026

NVIDIA Expands NVIDIA Agent Toolkit With NVIDIA PhysicsNeMo and CUDA-X Libraries to Transform How the World Engineers, Designs and BuildsNVIDIA expanded its Agent Toolkit with re-architected PhysicsNeMo libraries and updated CUDA-X libraries, enabling developers to build autonomous AI engineers with physics simulation and quantum chemistry capabilities. The Nemotron 3 Ultra model leads in agentic RTL coding for chip design. Industry leaders including Cadence, Siemens, Synopsys, Samsung, and others are deploying these technologies to accelerate chip design, verification, and engineering workflows with significant performance improvements.GlobeNewswire Inc. · Jul 27, 2026

Cadence Design Systems vs. Synopsys: Which Technology Stock Is a Better Buy in 2026?Both Cadence Design Systems and Synopsys are leaders in chip design software, benefiting from strong semiconductor demand. Cadence offers a cleaner growth story with record backlogs and strong profitability, while Synopsys provides broader capabilities through its Ansys acquisition but faces integration complexity and higher valuation multiples. The article recommends Cadence as the better 2026 buy due to its simpler execution and stronger balance sheet.The Motley Fool · Jul 14, 2026

SN

SNPSSynopsys Inc

SNPS

Pay with—

Available Balance0.00

Your PositionYou don't own any SNPS yet.

Related Tickers

Earnings